These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 2540559)

  • 21. A prospective study of rapid methods of detecting cytomegalovirus in the blood of renal transplant recipients in relation to patient and graft survival.
    Eriksson BM; Wirgart BZ; Claesson K; Tufveson G; Magnusson G; Tötterman T; Grillner L
    Clin Transplant; 1996 Dec; 10(6 Pt 1):494-502. PubMed ID: 8996769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnosing cytomegalovirus disease in CMV seropositive renal allograft recipients: a comparison between the detection of CMV DNAemia by polymerase chain reaction and antigenemia by CMV pp65 assay.
    Lo CY; Ho KN; Yuen KY; Lui SL; Li FK; Chan TM; Lo WK; Cheng IK
    Clin Transplant; 1997 Aug; 11(4):286-93. PubMed ID: 9267717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Who among cytomegalovirus-seropositive liver transplant recipients is at risk for cytomegalovirus infection?
    Singh N; Wannstedt C; Keyes L; Wagener MM; Cacciarelli TV
    Liver Transpl; 2005 Jun; 11(6):700-4. PubMed ID: 15915496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HLA-DQ3 is a probable risk factor for CMV infection in high-risk kidney transplant patients.
    Varga M; Rajczy K; Telkes G; Hídvégi M; Péter A; Remport A; Korbonits M; Fazakas J; Toronyi E; Sárváry E; Kóbori L; Járay J
    Nephrol Dial Transplant; 2008 Aug; 23(8):2673-8. PubMed ID: 18332066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prospective study of cytomegalovirus infections in 211 children with kidney transplants].
    Cabau N; Gagnadoux MF; Niaudet P; Duros C; Broyer M; Boue A
    Sem Hop; 1983 Dec; 59(44):3038-41. PubMed ID: 6320390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term renal graft function and survival in patients with high-risk for cytomegalovirus infection receiving preemptive therapy.
    Alberú J; Morales-Buenrostro LE; Correa-Rotter R; Muñoz-Trejo T; Zúñiga-Varga J; Cuéllar-González JV; Mayorga-Madrigal H; Vanegas-Carrero R; Aranda F; Rodríguez-Romo R; Herrera-Garcia C; González-Michaca L; Sierra-Madero JG
    Rev Invest Clin; 2008; 60(5):365-74. PubMed ID: 19227433
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Results of prospective matching for cytomegalovirus status in renal transplant recipients.
    Ludwin D; White N; Tsai S; Chernesky M; Achong M; Smith EK
    Transplant Proc; 1987 Aug; 19(4):3433-4. PubMed ID: 3039700
    [No Abstract]   [Full Text] [Related]  

  • 28. [The frequency of cytomegalovirus infection (CMV) in patients immunocompromised patients with malignant and nonmalignant blood disorders].
    Zawilińska B; Weglarska D; Gruszka AM; Skotnicki AB; Zgórniak-Nowosielska I
    Acta Haematol Pol; 1996; 27(1):65-71. PubMed ID: 8629446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Failure to prevent cytomegalovirus infection by cytomegalovirus hyperimmune plasma: a randomized trial by the Nordic Bone Marrow Transplantation Group.
    Ringdén O; Pihlstedt P; Volin L; Nikoskelainen J; Lönnqvist B; Ruutu P; Ruutu T; Toivanen A; Wahren B
    Bone Marrow Transplant; 1987 Oct; 2(3):299-305. PubMed ID: 2844340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of cytomegalovirus serostatus on outcome of unrelated cord blood transplantation for adults: a single-institute experience in Japan.
    Tomonari A; Takahashi S; Ooi J; Tsukada N; Konuma T; Kato S; Kasahara S; Iseki T; Yamaguchi T; Tojo A; Asano S
    Eur J Haematol; 2008 Mar; 80(3):251-7. PubMed ID: 18081702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical course of cytomegalovirus infection in renal transplant recipients].
    Luchsinger V; Suárez M; Montiel F; Kaltwasser G
    Rev Med Chil; 1999 Jan; 127(1):9-17. PubMed ID: 10436673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [pp65 antigenemia in evaluation of cytomegalovirus infection after kidney transplantation].
    Orlić P; Dvornik S; Husnjak SC; Aralica M; Orlić L; Zivcić-Cosić S; Sladoje-Martinović B; Fućak M
    Acta Med Croatica; 2003; 57(1):49-52. PubMed ID: 12876863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytomegalovirus infection and kidney transplants: contribution of systematic cytomegalovirus blood detection by antigenemia and polymerase chain reaction.
    Gratacap-Cavallier B; Morand P; Bayle F; Buthod N; Therin N; Janbon B; Seigneurin JM
    Transplant Proc; 1995 Aug; 27(4):2449. PubMed ID: 7652876
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of cytomegalovirus infection on renal function in kidney transplant recipients.
    Choi SJ; Kim NH; Cho CK; Chung SY; Kim HJ; Choi KC; Kim SK
    Transplant Proc; 1996 Jun; 28(3):1523-4. PubMed ID: 8658769
    [No Abstract]   [Full Text] [Related]  

  • 35. Cytomegalovirus infection in heart transplant recipients is associated with impaired endothelial function.
    Petrakopoulou P; Kübrich M; Pehlivanli S; Meiser B; Reichart B; von Scheidt W; Weis M
    Circulation; 2004 Sep; 110(11 Suppl 1):II207-12. PubMed ID: 15364864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytomegalovirus infection in burn patients.
    Kealey GP; Bale JF; Strauss RG; Massanari RM
    J Burn Care Rehabil; 1987; 8(6):543-5. PubMed ID: 2830289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of cytomegalovirus infection in the pediatric renal transplant recipient.
    Hibberd PL; Rubin RH
    Pediatr Nephrol; 1991 Jan; 5(1):112-7. PubMed ID: 1851031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of cytomegalovirus-seropositive donor kidneys in seronegative patients: results of prospective serotesting and matching in one center.
    Henell KR; Chou S; Norman DJ
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2082-3. PubMed ID: 2540559
    [No Abstract]   [Full Text] [Related]  

  • 39. [incidence of cytomegalovirus infections following transplantation of kidneys from seropositive and seronegative donors].
    Kaden J; Adamczyk G; Eichler C; Strobelt V; Groth J; Janisch W; May G
    Z Urol Nephrol; 1985 May; 78(5):267-71. PubMed ID: 2994321
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transplanting kidneys from CMV-seropositive donors to CMV-seronegative recipients is not associated with poorer renal allograft function or survival.
    McLaughlin K; Sandhu S; Wu C; Muirhead N; Hollomby D; Jevnikar A
    Nephrol Dial Transplant; 2005 Jan; 20(1):176-80. PubMed ID: 15572381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.